Cover Image

Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose

Jorge Eduardo Toblli, Margarita Angerosa Nephrology Section, Department of Internal Medicine, Hospital Alemán, School of Medicine, University of Buenos Aires, Argentina Abstract: With the challenge of optimizing iron delivery, new intravenous (iv) iron–carbohydrate complexes hav...

Full description

Saved in:

Bibliographic Details
Main Authors:	Toblli JE (Author), Angerosa M (Author)
Format:	Book
Published:	Dove Medical Press, 2014-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound
by: Toblli JE, et al.
Published: (2017)

Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany
by: Froessler B, et al.
Published: (2018)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018)

A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy
by: Sanjay Gupte, et al.
Published: (2024)

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
by: Ambily Jose, et al.
Published: (2019)

An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland
by: Pollock RF, et al.
Published: (2021)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018)

Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anaemia in Paediatric Patients with Anastomotic Ulcers
by: Chiara Udina, et al.
Published: (2022)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
by: Tilmann Kramer, et al.
Published: (2021)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018)

Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022)

Comparative analysis of ferric carboxymaltose and iron sucrose in treating iron deficiency anemia in perimenopausal women with heavy menstrual bleeding: a randomized controlled trial
by: Jaya Chaturvedi, et al.
Published: (2024)

Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnancy: A Subgroup Analysis of a Multicenter Real-World Study Involving 1191 Pregnant Women
by: Prakash Trivedi, et al.
Published: (2022)

Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis
by: Winghan Jacqueline Kwong, et al.
Published: (2024)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up
by: Antonio Lacquaniti, et al.
Published: (2020)

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease
by: Patricia Garcia-Ortega, et al.
Published: (2022)

Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats
by: Toblli JE, et al.
Published: (2015)

Ferric sodium edetate therapy in children with iron deficiency anemia
by: Christie Moningkey, et al.
Published: (2015)

Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
by: Anouk Pels, et al.
Published: (2015)

Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds
by: Toblli JE, et al.
Published: (2017)

Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
by: Lea Bombač Tavčar, et al.
Published: (2023)

Intravenous Ferric Carboxymaltose as Rescue Therapy in Severe Breath Holding Spells: A Case Report and Literature Review
by: Hee Jeong Yun, et al.
Published: (2022)

Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study
by: Shashi Kant, et al.
Published: (2020)

Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain
by: Rafael Aporta Rodriguez, et al.
Published: (2016)

Comparing the efficacy between ferrous carboxymaltose and iron sucrose therapy in iron deficiency anemia during pregnancy in Obstetrics and Gynecology ward at tertiary care hospital, Jaipur
by: Kamal Saini, et al.
Published: (2020)

FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
by: T. Christopher Bond, et al.
Published: (2012)

Parenteral iron therapy for anaemia in pregnancy: ferric carboxy maltose versus iron sucrose
by: Sudha R, et al.
Published: (2022)

The ferric conundrum: which intravenous iron preparations are preferred for chronic kidney disease patients?
by: Aimee Hechanova, et al.
Published: (2022)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
by: Yulia Grishchuk, et al.
Published: (2015)

Positive effects of ferric iron on the systemic efficacy of nephrilin peptide in burn trauma
by: Desmond D Mascarenhas, et al.
Published: (2020)

Economic Analysis of Intravenous Iron in Patients with Iron Deficiency Anemia Due to Inflammatory Bowel Disease: Considerations for Clinicians [Letter]
by: Pollock RF, et al.
Published: (2022)

Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
by: Fabiana Busti, et al.
Published: (2018)

Optimizing the Approach to the Treatment of Iron-Deficiency Anemia in Children
by: Ye.I. Yulish
Published: (2015)

IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency
by: Itay Borreda MD, et al.
Published: (2022)

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
by: Xueying Ding, et al.
Published: (2024)

The Role of Malondialdehyde (MDA) and Ferric Reducing Antioxidant Power (FRAP) in Patients with Hypertension
by: Roshan Alam, et al.
Published: (2023)

Iron deficiency anemia and megaloblastic anemia in obese patients
by: Arshad Mahmoud, et al.
Published: (2017)

Iron deficiency anemia in pregnancy: evaluation and management.
by: Aleksandra Obuchowska, et al.
Published: (2022)

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
by: Fragoulakis V, et al.
Published: (2012)

The role of DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia
by: Jeanette Manoppo, et al.
Published: (2019)